Product Information

FYCOMPA 2 MG TABLET is a brand product labeled by Catalyst Pharmaceuticals, Inc., priced at $19.7404 per EA under NDC 69616027230. Its NADAC has been published 133 times since Feb 7, 2024.

FDA first approved this application on Oct 22, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FYCOMPA 2 MG TABLET

perampanel
$19.7404per EA
DEA Schedule CIII

Strength

2 mg/1

NDC

69616027230

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PERAMPANEL

Approval Type

New Drug (NDA)

FDA Application

NDA202834

FDA Approved

10/22/2012

TE Code

AB

On Market Since

1/2/2024

Pharmacological Classes

AMPA Receptor Antagonists
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 3A4 Inhibitors
Noncompetitive AMPA Glutamate Receptor Antagonist
UGT1A9 Inhibitors
UGT2B7 Inhibitors

Price Statistics

The NADAC for FYCOMPA 2 MG TABLET has been published 133 times since Feb 7, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$19.7404 per EA
All-time high$19.8816 (Jun 12, 2024)
All-time low$19.7368 (Jul 22, 2026)
52-week high$19.8161
52-week low$19.7368
Median price$19.8148
Average price$19.8030
Largest weekly change+0.6% (May 22, 2024)
Weeks tracked133
Tracking sinceFeb 7, 2024

Price History

1W

+0.0%

1M

+0.0%

3M

-0.1%

6M

-0.1%

1Y

-0.4%

3Y

N/A

5Y

N/A

All

-0.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of FYCOMPA 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FYCOMPA 2 MG TABLET, manufactured by Catalyst Pharmaceuticals, Inc., is $19.7404 per EA (NDC 69616027230), effective Aug 19, 2026.

How has the price of FYCOMPA 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for FYCOMPA 2 MG TABLET has held within roughly two percent of its current level. It has been tracked across 133 weekly CMS publications since Feb 7, 2024.

What are the highest and lowest recorded NADAC prices for FYCOMPA 2 MG TABLET?

Since Feb 7, 2024, the NADAC for FYCOMPA 2 MG TABLET has ranged from a low of $19.7368 (Jul 22, 2026) to a high of $19.8816 (Jun 12, 2024), with a median of $19.8148 per EA.

Are there cheaper alternatives to FYCOMPA 2 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FYCOMPA 2 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FYCOMPA 2 MG TABLET?

FYCOMPA 2 MG TABLET (NDC 69616027230) is labeled by Catalyst Pharmaceuticals, Inc., and CMS classifies it as a brand product.